1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
Delayed Swiss Exchange  -  11:31 2022-08-12 am EDT
62.30 CHF   -0.95%
07/22BB Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
07/22Swiss Investor BB Biotech Posts H1 Loss Amid Difficult Macroeconomic Environment
MT
07/22BB Biotech AG publishes its interim report
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BB Biotech Swings To Q1 Loss As Total Returns Plummet

04/22/2022 | 01:36am EDT


© MT Newswires 2022
All news about BB BIOTECH AG
07/22BB Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended June..
CI
07/22Swiss Investor BB Biotech Posts H1 Loss Amid Difficult Macroeconomic Environment
MT
07/22BB Biotech AG publishes its interim report
EQ
07/22BB BIOTECH AG : First signs of increased M&A activity due to attractive valuations
EQ
07/22BB BIOTECH : Q2 Interim Report
PU
07/22BB BIOTECH : Q2 Financial_Report
PU
05/24BB BIOTECH AG : Disruptive technologies are changing an entire industry
EQ
04/22BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22BB Biotech Swings To Q1 Loss As Total Returns Plummet
MT
04/22BB Biotech AG publishes its interim report
EQ
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Financials
Sales 2022 -298 M -316 M -316 M
Net income 2022 259 M 275 M 275 M
Net Debt 2022 283 M 300 M 300 M
P/E ratio 2022 -9,60x
Yield 2022 6,18%
Capitalization 3 426 M 3 632 M 3 632 M
EV / Sales 2022 -12,4x
EV / Sales 2023 7,41x
Nbr of Employees 10
Free-Float 97,7%
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 62,30 CHF
Average target price 78,60 CHF
Spread / Average Target 26,2%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG-19.25%3 632
MODERNA, INC.-32.60%66 966
IQVIA HOLDINGS INC.-12.88%45 846
LONZA GROUP AG-25.13%44 851
SEAGEN INC.10.05%31 380
ALNYLAM PHARMACEUTICALS, INC.37.90%28 068